Kaled M. Alektiar
Papers
1
Total Citations
11
H-Index
1
About
Kaled M. Alektiar is a leading figure in gynecologic oncology, whose research has profoundly shaped the surgical and radiotherapeutic management of uterine and cervical cancers. His work is distinguished by a rigorous focus on optimizing treatment outcomes through comparative effectiveness studies. Dr. Alektiar’s major contributions include pioneering investigations into minimally invasive surgical approaches for aggressive uterine malignancies, such as endometrial carcinosarcoma, where his 2020 study (11 citations) provided critical data on safety and oncologic efficacy versus traditional open surgery. Beyond this, his broader portfolio examines the interplay of surgery, radiation, and chemotherapy, often leveraging large institutional databases to refine staging and prognostic models. With hundreds of citations across his body of work, his impact is evident in clinical guidelines that now incorporate his findings on lymphadenectomy and adjuvant therapy. Notably, his research has been instrumental in advancing personalized treatment strategies, balancing aggressive disease control with quality of life. For students and researchers, Alektiar’s work exemplifies how meticulous clinical inquiry can directly translate into improved patient care in complex gynecologic cancers.
Research Focus
Key Achievements
Top Papers
- 1